Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5090509
Max Phase: Preclinical
Molecular Formula: C37H51FN4O4S
Molecular Weight: 666.90
Molecule Type: Unknown
Associated Items:
ID: ALA5090509
Max Phase: Preclinical
Molecular Formula: C37H51FN4O4S
Molecular Weight: 666.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)N[C@H]1CCC[C@@H]1[C@](CN1CCC1)(c1cccc(F)c1)C1CCN(CC2(C)CN(c3ccc(S(=O)(=O)C4CC4)cc3)C2)CC1
Standard InChI: InChI=1S/C37H51FN4O4S/c1-36(24-42(25-36)30-10-12-31(13-11-30)47(44,45)32-14-15-32)23-41-20-16-27(17-21-41)37(26-40-18-5-19-40,28-6-3-7-29(38)22-28)33-8-4-9-34(33)39-35(43)46-2/h3,6-7,10-13,22,27,32-34H,4-5,8-9,14-21,23-26H2,1-2H3,(H,39,43)/t33-,34-,37-/m0/s1
Standard InChI Key: LIAWNGIPPNVPIC-YSJNHPSYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 666.90 | Molecular Weight (Monoisotopic): 666.3615 | AlogP: 5.47 | #Rotatable Bonds: 11 |
Polar Surface Area: 82.19 | Molecular Species: BASE | HBA: 7 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 8.93 | CX LogP: 4.92 | CX LogD: 3.00 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.34 | Np Likeness Score: -1.03 |
1. Zhang M, Aguilar A, Xu S, Huang L, Chinnaswamy K, Sleger T, Wang B, Gross S, Nicolay BN, Ronseaux S, Harvey K, Wang Y, McEachern D, Kirchhoff PD, Liu Z, Stuckey J, Tron AE, Liu T, Wang S.. (2021) Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression., 64 (14.0): [PMID:34196551] [10.1021/acs.jmedchem.1c00789] |
Source(1):